Holen Sie sich die Stockscreener-App
304.79
0.05%
-0.16
Handel nachbörslich:
304.79
Schlusskurs vom Vortag:
$304.95
Offen:
$304.79
24-Stunden-Volumen:
349.00K
Relative Volume:
0.62
Marktkapitalisierung:
$12.07B
Einnahmen:
$3.88B
Nettoeinkommen (Verlust:
$640.71M
KGV:
21.76
EPS:
14.0042
Netto-Cashflow:
$1.16B
1W Leistung:
+6.86%
1M Leistung:
+5.46%
6M Leistung:
-6.37%
1J Leistung:
+85.90%
1-Tages-Spanne:
$302.36
$309.89
1-Wochen-Bereich:
$288.80
$309.89
52-Wochen-Spanne:
$148.63
$388.71
Evercore Inc Stock (EVR) Company Profile
Firmenname
Evercore Inc
Sektor
Branche
Telefon
212-857-3100
Adresse
55 EAST 52ND STREET, NEW YORK, NY
Compare EVR vs MS, GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
304.79 | 12.08B | 3.88B | 640.71M | 1.16B | 14.00 |
MS
Morgan Stanley
|
166.55 | 263.28B | 119.71B | 17.03B | 46.10B | 10.21 |
GS
Goldman Sachs Group Inc
|
866.05 | 254.59B | 126.15B | 17.18B | 23.15B | 51.30 |
SCHW
Charles Schwab Corp
|
92.99 | 164.30B | 27.68B | 8.85B | 13.27B | 4.6601 |
HOOD
Robinhood Markets Inc
|
69.78 | 62.03B | 4.51B | 1.88B | -3.42B | 2.059 |
IBKR
Interactive Brokers Group Inc
|
68.62 | 30.19B | 10.43B | 4.36B | 24.23B | 2.2152 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Eingeleitet | BofA Securities | Buy |
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-09 | Eingeleitet | Deutsche Bank | Buy |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-06-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-04-08 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-20 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-11 | Hochstufung | Goldman | Neutral → Buy |
| 2024-01-29 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2024-01-09 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-22 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-12 | Hochstufung | UBS | Sell → Buy |
| 2023-01-11 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-09-23 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-09 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-03-19 | Bestätigt | Goldman | Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-12-16 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-12-01 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-08-05 | Hochstufung | Goldman | Neutral → Buy |
| 2020-07-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-06 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-14 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-05-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2018-11-06 | Eingeleitet | Goldman | Neutral |
| 2018-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2017-05-23 | Herabstufung | Goldman | Buy → Neutral |
| 2017-03-27 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2017-02-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-02-13 | Herabstufung | Instinet | Buy → Neutral |
| 2016-12-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2016-11-21 | Fortgesetzt | Credit Suisse | Outperform |
Alle ansehen
Evercore Inc Aktie (EVR) Neueste Nachrichten
Evercore ISI Group Lowers SYF Price Target to $80, Maintains Out - gurufocus.com
MAA: Evercore ISI Group Lowers Price Target to $126 | MAA Stock News - gurufocus.com
AZTA: Evercore ISI Group Lowers Price Target Amidst Maintained R - gurufocus.com
Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target | - gurufocus.com
Evercore ISI Group Adjusts Price Target for ENOV, Maintains "Out - gurufocus.com
Boston Scientific (BSX) Price Target Lowered by Evercore ISI Gro - gurufocus.com
EastGroup Properties (EGP): Evercore ISI Lowers Price Target, Ma - gurufocus.com
C: Evercore ISI Group Lowers Citigroup's Price Target to $115 | - gurufocus.com
ESS: Evercore ISI Group Lowers Price Target to $264 | ESS Stock News - gurufocus.com
Evercore ISI Group Lowers Price Target for EQR, Maintains Outper - gurufocus.com
CFR: Evercore ISI Group Adjusts Target Price, Maintains In-Line Rating | CFR Stock News - gurufocus.com
AVB Analyst Rating Update: Target Price Lowered by Evercore ISI Group | AVB Stock News - gurufocus.com
JPMorgan Stock Price Targets Reset as Evercore Cuts to $320, Piper Holds Overweight - TechStock²
Evercore ISI Lowers Price Target for Abbott Laboratories (ABT) t - gurufocus.com
ALLY: Evercore ISI Lowers Price Target while Maintaining Outperf - gurufocus.com
Keurig Dr Pepper (KDP) Receives In Line Rating from Evercore ISI - gurufocus.com
Evercore ISI Adjusts Price Target on Alexandria Real Estate Equities to $65 From $67, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Welltower PT to $225 From $221, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Ventas Price Target to $94 From $90, Maintains Outperform Rating - marketscreener.com
Huntington Bancshares (NASDAQ:HBAN) Price Target Lowered to $19.00 at Evercore - MarketBeat
Evercore Lowers Capital One Financial (NYSE:COF) Price Target to $222.00 - MarketBeat
Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00 - MarketBeat
Evercore Lowers KeyCorp (NYSE:KEY) Price Target to $24.00 - MarketBeat
Evercore Issues Pessimistic Forecast for JPMorgan Chase & Co. (NYSE:JPM) Stock Price - MarketBeat
Evercore Cuts Equity Residential (NYSE:EQR) Price Target to $67.00 - MarketBeat
Evercore Issues Positive Forecast for EQT (NYSE:EQT) Stock Price - MarketBeat
Fifth Third Bancorp (NASDAQ:FITB) Price Target Cut to $51.00 by Analysts at Evercore - MarketBeat
Evercore ISI Adjusts Baxter International Price Target to $22 From $23, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Revvity Price Target to $108 From $118, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Equity Residential Price Target to $67 From $70, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $160, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Mettler-Toledo International PT to $1,425 From $1,515, Maintains Outperform Rating - marketscreener.com
Waters (NYSE:WAT) Stock Rating Upgraded by Evercore - MarketBeat
Evercore ISI Adjusts Boston Scientific Price Target to $80 From $96, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Danaher Price Target to $225 From $254, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts GE Healthcare Technologies PT to $85 From $98, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Intuitive Surgical to $480 From $550, Maintains In Line Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Bio-Techne to $54 From $68, Maintains In Line Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Northern Trust to $140 From $155, Maintains In Line Rating - marketscreener.com
Evercore ISI Adjusts PT on Mid-America Apartment Communities to $126 From $141, Keeps In Line Rating - marketscreener.com
Evercore ISI Adjusts PT on Essex Property Trust to $264 From $269, Maintains In Line Rating - marketscreener.com
Evercore ISI Adjusts PT on AvalonBay Communities to $191 From $202, Maintains In Line Rating - marketscreener.com
Evercore ISI Upgrades Waters to Outperform From In Line, Adjusts Price Target to $350 From $360 - marketscreener.com
Evercore ISI Adjusts Price Target on Synchrony Financial to $80 From $88, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Capital One Financial to $222 From $265, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Citizens Financial Group to $70 From $77, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on American Express to $330 From $393, Maintains In Line Rating - marketscreener.com
Evercore ISI Adjusts Price Target on EQT to $70 From $60, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Huntington Bancshares to $19 From $21, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Diamondback Energy to $255 From $245, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts PT on Goldman Sachs to $950 From $1,075, Maintains Outperform Rating - marketscreener.com
Finanzdaten der Evercore Inc-Aktie (EVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):